Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

121.46
Delayed Data
As of 3:59pm ET
 -1.11 / -0.91%
Today’s Change
97.52
Today|||52-Week Range
169.89
-15.32%
Year-to-Date
No recent news for United Therapeutics Corp.

Today’s Trading

Previous close122.57
Today’s open122.55
Day’s range120.51 - 122.55
Volume274,179
Average volume (3 months)623,333
Market cap$5.5B
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-8.88%
Earnings growth (next 5 years)-6.70%
Revenue growth (last year)+9.08%
P/E ratio8.5
Price/Sales4.20
Price/Book2.82

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.08-0.37%
IONSIonis Pharmaceutical...+0.38+0.85%
PTHNPatheon NV-0.05-0.14%
ALNYAlnylam Pharmaceutic...+0.94+1.27%
Data as of 4:02pm ET, 05/23/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$3.49
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts